Gretchen Nalley, FNP-BC
NPI 1376973909 · Nurse Practitioner · Silverdale, WA
Enrolled with Medicare as Practitioner - Nurse Practitioner · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1376973909
- Entity type
- Individual
- Primary specialty
- Nurse PractitionerPhysician Assistants & Advanced Practice Nursing Providers
- Credential
- FNP-BC
- Sex
- Female
- Sole proprietor
- Yes
- License
- AP60486241 (WA)
Specialties & taxonomies
Physician Assistants & Advanced Practice Nursing Providers
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
12 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
299 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 105 | $108 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 87 | $77 |
| Professional Service for Multiple Injections of Allergen95117 | 24 | $11 |
| Professional Service for Single Injection of Allergen95115 | 22 | $9 |
| Test to Measure Rate of Airflow94375 | 20 | $32 |
| Administration and Interpretation of Patient-Focused Health Risk Assessment96160 | 16 | $3 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 20 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Fluticasone/Umeclidin/Vilanterbrand: Trelegy Ellipta | 79 | 16 |
| Fluticasone/Vilanterolbrand: Breo Ellipta | 54 | — |
| Albuterol Sulfatebrand: Albuterol Sulfate Hfa | 46 | 26 |
| Fluticasone Propionate | 44 | 17 |
| Ipratropium Bromide | 38 | 12 |
| Dupilumabbrand: Dupixent Pen | 37 | — |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$825 across 35 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2013-11-18
- Last updated
- 2025-09-17
- Certified
- 2025-09-17
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.